GlassScriptPhysician profile
Brandon J Murphy
NPI 1417290834
$2,530.70
in general payments reported to CMS, 2019-2025
29 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $561 · 2020: $334 · 2021: $338 · 2022: $338 · 2023: $236 · 2024: $571 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $960.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $959.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $935.80 | 2019-2024 | Da Vinci Surgical System |
| Tela Bio, INC. | $235.62 | 2021-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $210.80 | 2019-2023 | Phasix Mesh |
| Medtronic, INC. | $186.98 | 2022-2024 | V-Loc 180 |
| Medical Device Business Services, INC. | $121.67 | 2019 | |
| Convatec INC. | $92.38 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $85.14 | 2020-2024 | Gattex |
| Smith+Nephew, INC. | $75.21 | 2022-2025 | Renasys Go V2 Home, Renasys Touch |
| Kerecis Limited | $59.61 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Kci USA, INC. | $48.72 | 2020-2022 | |
| Baxter Healthcare | $45.27 | 2024-2025 | Perclot, Tisseel |
| Sanofi Pasteur INC. | $43.66 | 2022-2024 | |
| Organogenesis INC. | $42.77 | 2022 | |
| Ethicon US, LLC | $35.79 | 2020 | |
| Integra Lifesciences Corporation | $29.82 | 2024 | Integra, Omnigraft, Surgimend |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.79 | 2021-2024 | Xifaxan |
| Merck Sharp & Dohme LLC | $27.06 | 2019 | |
| Distalmotion US | $25.48 | 2025 | Dexter L6 Robot |
| Avanos Medical | $24.30 | 2023 | Peg |
| Stryker Corporation | $23.04 | 2022 | |
| Innocoll Pharmaceuticals Limited | $21.42 | 2021 | |
| Tetraphase Pharmaceuticals, INC. | $20.65 | 2019 | |
| Baudax Bio INC. | $19.03 | 2022 | |
| Janssen Biotech, INC. | $18.86 | 2025 | Tremfya |
| Z-Medica, LLC | $15.61 | 2019 | |
| Conmed Corporation | $14.72 | 2024 | Airseal |
| Allergan, INC. | $14.50 | 2020 | |
| Lucid Diagnostics INC. | $14.36 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $13.64 | 2025 | Caldolor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.